Molecular cloning and anti-HIV-1 activities of APOBEC3s from northern pig-tailed macaques (Macaca leonina)

Xiao-Liang Zhang1, Jia-Hao Song2, Wei Pang3

  • 1Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming Yunnan 650223, China;Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming Yunnan 650500, China.

Insights

Northern pig-tailed macaques (Macaca leonina) possess APOBEC3G and APOBEC3F, which significantly inhibit HIV-1 replication. These findings are crucial for developing better HIV-1 monkey models.

Area of Science:

  • Virology
  • Immunology
  • Primatology

Background:

  • Northern pig-tailed macaques (Macaca leonina) are susceptible to HIV-1 due to TRIM5α deficiency.
  • Despite TRIM5α loss, persistent HIV-1 replication suggests other host restriction factors are present.
  • The role of APOBEC3 proteins in restricting HIV-1 in Macaca leonina was previously unknown.

Purpose of the Study:

  • To investigate the anti-HIV-1 activity of APOBEC3 proteins in Northern pig-tailed macaques.
  • To identify specific APOBEC3 members that inhibit HIV-1 replication in this primate model.

Main Methods:

  • Cloning of Northern pig-tailed macaque APOBEC3A-APOBEC3H genes.
  • BLAST analysis to compare coding sequences with related macaque species.
  • Assessment of anti-HIV-1 activities of cloned APOBEC3 genes.

Main Results:

  • The coding sequences of NPM APOBEC3 genes showed 99% identity to those of rhesus and southern pig-tailed macaques.
  • APOBEC3G and APOBEC3F exhibited the most potent anti-HIV-1 activity among the tested APOBEC3 members.
  • Other APOBEC3 members demonstrated less significant inhibition of HIV-1 replication.

Conclusions:

  • APOBEC3G and APOBEC3F likely play a significant role in limiting in vivo HIV-1 replication in Northern pig-tailed macaques.
  • This study provides essential data for refining macaque models used in HIV-1 research.
  • Understanding these host restriction factors can aid in the development of novel HIV-1 therapies.

Related Concept Videos